US Asset Management LLC’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-711
Closed -$109K 192
2023
Q1
$109K Sell
711
-4
-0.6% -$660 0.11% 159
2022
Q4
$128K Buy
+715
New +$117K 0.14% 153
2022
Q2
$102K Buy
717
+642
+856% +$91.8K 0.11% 163
2022
Q1
$13K Buy
+75
New +$12.6K 0.01% 240
2021
Q4
Sell
-150
Closed -$58K 194
2021
Q3
$58K Buy
+150
New +$55.3K 0.06% 194

Other funds holding MRNA

US Asset Management LLC's MRNA Position: Q2 2023 in Review

US Asset Management LLC sold out of Moderna (MRNA) in Q2 2023, closing a stake of 711 shares — an estimated $109K sold.

US Asset Management LLC first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $128K in Q4 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • US Asset Management LLC reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • US Asset Management LLC sold 711 Moderna shares in Q2 2023, an estimated $109K.
  • US Asset Management LLC first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
  • US Asset Management LLC's Moderna position peaked at $128K in Q4 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on US Asset Management LLC's 13F filing for Q2 2023, filed 22 Aug 2023.